Spanish fertility clinic, Clinica Eugin, is in the final stages of being sold after attracting 67 bids from large private equity players in September.
The NMC-owned business was put up for sale by the group’s administrators Alvarez & Marsal earlier this year.
Investor CVC and Spanish private hospital group Quirónsalud, part of Fresenius Helios, are expected to win ahead of competing bids from private equity firm HIG, according to Expansión.
Previous potential candidates to acquire the fertility business included companies such as Cinven, Bridgepoint, KKR and EQT.
The sale is reportedly valued at around €300m, similar figures to the value from September of €350-400m (US$413-472m).
Proceeds from the deal are likely to be set aside for debt payments by Eugin’s owner NMC Health, which acquired an 86.4% stake in Eugin from Proa in 2015.